X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
humans (57) 57
oncology (52) 52
urology & nephrology (50) 50
cancer (41) 41
male (37) 37
aged (35) 35
middle aged (34) 34
chemotherapy (30) 30
female (30) 30
urology (30) 30
treatment outcome (26) 26
care and treatment (24) 24
bladder cancer (23) 23
aged, 80 and over (19) 19
antineoplastic agents - therapeutic use (18) 18
prognosis (18) 18
research (18) 18
retrospective studies (18) 18
urothelial carcinoma (17) 17
survival (16) 16
radical cystectomy (14) 14
analysis (13) 13
disease-free survival (13) 13
metastasis (13) 13
prostate cancer (13) 13
transitional-cell carcinoma (13) 13
adjuvant chemotherapy (12) 12
cisplatin (12) 12
drug therapy (12) 12
gemcitabine (12) 12
neoadjuvant chemotherapy (12) 12
survival rate (12) 12
therapy (12) 12
urinary bladder neoplasms - pathology (12) 12
carcinoma (11) 11
docetaxel (11) 11
adult (10) 10
cystectomy (10) 10
hematology, oncology and palliative medicine (10) 10
patient outcomes (10) 10
proportional hazards models (10) 10
abridged index medicus (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
clinical trials (9) 9
neoplasm metastasis (9) 9
survival analysis (9) 9
article (8) 8
bladder-cancer (8) 8
carcinoma, transitional cell - drug therapy (8) 8
men (8) 8
neoplasm invasiveness (8) 8
neoplasm staging (8) 8
oncology, experimental (8) 8
open-label (8) 8
perioperative chemotherapy (8) 8
phase-iii trial (8) 8
urinary bladder neoplasms - drug therapy (8) 8
urinary bladder neoplasms - therapy (8) 8
usage (8) 8
abiraterone (7) 7
adjuvant treatment (7) 7
antineoplastic agents - adverse effects (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
breast cancer (7) 7
diagnosis (7) 7
double-blind (7) 7
impact (7) 7
medicine & public health (7) 7
neoadjuvant therapy (7) 7
quality of life (7) 7
urinary bladder neoplasms (7) 7
urinary bladder neoplasms - mortality (7) 7
urologic neoplasms - drug therapy (7) 7
antimitotic agents (6) 6
antineoplastic agents (6) 6
breast-cancer (6) 6
cancer therapies (6) 6
development and progression (6) 6
doxorubicin (6) 6
expression (6) 6
health aspects (6) 6
mortality (6) 6
multicenter (6) 6
nomogram (6) 6
original research (6) 6
patients (6) 6
prospective studies (6) 6
prostatic neoplasms, castration-resistant - drug therapy (6) 6
time factors (6) 6
trial (6) 6
animals (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
breast neoplasms - drug therapy (5) 5
carcinoma, transitional cell - pathology (5) 5
chemotherapy, adjuvant (5) 5
dose-response relationship, drug (5) 5
drug administration schedule (5) 5
follow-up studies (5) 5
kaplan-meier estimate (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Canadian Urological Association Journal, ISSN 1911-6470, 11/2019, Volume 13, Issue 12
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 464 - 464
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 245 - 245
245 Background: Eligibility criteria for advanced (metastatic and locally advanced) prostate cancer trials vary between trials and are specific to the therapy... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2019, Volume 37, Issue 7_suppl, pp. 98 - 98
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 67 - 76
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 6550 - 6550
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 465 - 465
465 Background: Treatments for metastatic renal cell carcinoma (mRCC) are often compared across trials, but trial eligibility criteria and endpoints differ. In... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 374 - 374
374 Background: Enzalutamide (E) improves survival in men with metastatic castration-resistant prostate cancer (mCRPC). Fatigue (F) while taking E is poorly... 
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 05/2017, Volume 13, Issue 5, pp. 309 - 315
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e16500 - e16500
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 3, pp. 476 - 477
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.